[@BPharmCatalyst](/creator/twitter/BPharmCatalyst) "BioPharmCatalyst Weekly #Watchlist Key PDUFA and Regulatory Catalysts for the Next 6 Months $OMER $ABEO $RGNX $FBIO $CYTK $VNDA $OTLK $IONS $ARWR $TNXP $GRPH"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1944748119146586233) 2025-07-14 13:17:37 UTC 29.8K followers, 6854 engagements "$LGND today announced that its partner $PTHS has commercially launched ZELSUVMI (berdazimer) topical gel 10.3% the first and only FDA-approved at-home treatment for molluscum contagiosum. See More Biotech Updates👇 $CGTX $KLTO $RARE $MREO $CLDI $NTHI $PTHS"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1943416825594691696) 2025-07-10 21:07:32 UTC 29.8K followers, 5223 engagements "BioPharmCatalyst Weekly #Watchlist Key Phase 3 Catalysts for the Next 6 Months $ZYNE $PRAX $KPTI $AZN $DBVT $BTAI $AVBP $ABVX $XOMA $ENSC"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1939683693120913896) 2025-06-30 13:53:24 UTC 29.8K followers, 6189 engagements "$CLSD initiated a strategic review to explore options including asset sales partnerships or M&A to advance its SCS platform; Piper Sandler retained to lead the process. See More Biotech Updates👇 $WINT $SRPT $RCKT $FOLD $MBRX $CLSD $ICU"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1945943063223734497) 2025-07-17 20:25:54 UTC 29.8K followers, 5188 engagements "Want more info analysis and biotech news straight to your inbox Sign up for our FREE Daily and Weekly newsletters here:"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1945600565678879123) 2025-07-16 21:44:57 UTC 29.8K followers, 1357 engagements "🎧 New Episode Alert On Biotech Bulls and Breakthroughs John Gagliano and Sheff break down: 🔹 Key biotech market trends 🔹 Catalyst-driven trading strategies 🔹 Small-cap opportunities"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1944723047396909140) 2025-07-14 11:38:00 UTC 29.8K followers, 76.5K engagements "$NUWE announced the issuance by the U.S Patent and Trademark Office of U.S. Patent No. 12357734 titled "Extracorporeal Blood Filtering Machine and Methods." See More Biotech Updates👇 $SXTP $PMN $ANGO $BCTX $RANI $IKNA $KZR"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1945224122553802834) 2025-07-15 20:49:05 UTC 29.8K followers, 2865 engagements "BioPharmCatalyst Weekly #Watchlist Key PDUFA and Regulatory Catalysts for the Next 6 Months $OMER $ABEO $RGNX $FBIO $CYTK $VNDA $OTLK $IONS $ARWR $TNXP $GRPH"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1944023489872003526) 2025-07-12 13:18:12 UTC 29.8K followers, 6509 engagements "$INKT published new data in Oncogene highlighting a complete and durable remission in a patient with metastatic treatment-refractory testicular cancer treated with its iNKT cell therapy agenT-797. Additional case reports showed extended survival in several patients including 42% tumor reduction and 9+ months PFS in metastatic gastric cancer with agenT-797 + nivolumab. See More Pre-market Movers 👇 $CAPR $MIST $JUNS $PHVS"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1943642223838450072) 2025-07-11 12:03:11 UTC 29.8K followers, 5311 engagements "$SRPT announced a strategic restructuring to prioritize high-impact programs ensure financial sustainability through 2027 and focus on siRNA platform opportunities. The plan includes $400M in annual cost savings and a 36% workforce reduction (500 employees) aiming for long-term growth and profitability. See More Biotech Updates👇 $APM $CUE $CYCC $NUWE $QLGN $RPTX $GANX $CGTX $IKNA"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1945581687116648692) 2025-07-16 20:29:56 UTC 29.8K followers, 6415 engagements "$CGTX held an end-of-Phase 2 meeting with the FDA to review zervimesine (CT1812) data and discuss plans for a Phase 3 program to support a potential NDA in Alzheimer's disease. See More Pre-market Movers 👇 $KLTO $RARE $MREO $FONR $ALUR"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1943280274546061581) 2025-07-10 12:04:56 UTC 29.8K followers, 5907 engagements "BioPharmCatalyst Weekly #Watchlist Key Phase 1/2 catalyst for the next 6 months $CLLS $COGT $MRK $PMVP $GSK $MRSN $PEPG $ACIU $JSPR $CRSP $ENGN $JSPR $TIL"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1941512397379756538) 2025-07-05 15:00:01 UTC 29.8K followers, 4057 engagements "$MRK will acquire $VRNA for $107 per ADS in a deal valued at approximately $10 billion securing full ownership of Veronas respiratory drug assets. See More Pre-market Movers 👇 $KZIA $EVOK $PROK $ARTL $RXST $BCTX $BNTC $RYTM $ZVSA"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1942924985221161373) 2025-07-09 12:33:08 UTC 29.8K followers, 5629 engagements "$MBIO secured FDA Orphan Drug Designation for its IL-13R2-targeted CAR-T candidate MB-101 to treat malignant glioma unlocking eligibility for seven years of U.S. market exclusivity. See More Biotech Updates👇 $OGEN $CLRB $IGMS $VVOS $LIXT $ATAI $VRCA $MESO $MBIO"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1940149089422713011) 2025-07-01 20:42:43 UTC 29.8K followers, 2834 engagements "$EVOK received a USPTO Notice of Allowance for a patent covering GIMOTI use in moderate to severe gastroparesis expanding protection for its lead asset. See More Biotech Updates👇 $RXST $RYTM $BCTX $ZVSA $KZIA $VRNA $PROK"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1943042461086945637) 2025-07-09 20:19:57 UTC 29.8K followers, 5149 engagements "$WINT signed a $60M securities purchase agreement led by Build and Build Corp with the potential to raise a total of $200M to launch a BNB crypto treasury strategy. Subject to shareholder approval Windtree aims to become the first NASDAQ-listed company offering direct BNB token exposure. See More Pre-market Movers 👇 $WINT $SRPT $PRTC $RCKT $NUWE"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1945821738761150765) 2025-07-17 12:23:48 UTC 29.8K followers, 4261 engagements "$REVB announced that it will implement a 1-for-3 reverse stock split effective July 7 2025 following shareholder approval. See More Pre-market Movers 👇 $TIL $PTHS $CYBN $NLSP $GNTA"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1940388397651988664) 2025-07-02 12:33:39 UTC 29.8K followers, 5311 engagements "BioPharmCatalyst Weekly #Watchlist Key Catalysts Due in Mid-2025 $REPL $OTLK $RARE $WINT $ATAI $CYBN $IXHL $TNXP $VYNE $ATHE $PFE $CRDF $PRAX"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1946585823467717081) 2025-07-19 15:00:00 UTC 29.8K followers, 1333 engagements "$TELO reported promising data for Telomir-1 which showed it could reverse epigenetic gene silencing and restore tumor suppressors in human prostate cancer cells outperforming chemotherapy and rapamycin. See More Pre-market Movers 👇 $MESO $CNSP $SRPT $WINT $IINN"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1946183417592152183) 2025-07-18 12:20:59 UTC 29.8K followers, 1982 engagements "$MIST received a new PDUFA date of Dec 13 2025 for CARDAMYST nasal spray for PSVT after FDA accepted its CRL resubmission. The company also extended its $75M royalty deal with RTW through year-end. Separately Milestone priced a $52.5M public offering of common and pre-funded warrants at $1.50/share expected to close July 14 2025. See More Biotech Updates👇 $NCNA $INKT $MIST $CAPR $JUNS $PHVS $DARE"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1943766321692336191) 2025-07-11 20:16:19 UTC 29.8K followers, 6067 engagements "$SONN announced a business combination with Rorschach I LLC to form Hyperliquid Strategies Inc (HSI) a crypto treasury company expected to hold $888M in assets including 12.6M HYPE tokens and $305M in cash. HSI will remain listed on Nasdaq with backing from top crypto investors. See More Pre-market Movers 👇 $RANI $CELC $RARE $PRQR $IPA $EPIX $MGRM"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1944734466997428250) 2025-07-14 12:23:23 UTC 29.8K followers, 5011 engagements "BioPharmCatalyst Weekly #Watchlist Key Phase 3 Catalysts for the Next 6 Months $ZYNE $PRAX $KPTI $AZN $DBVT $BTAI $AVBP $ABVX $XOMA $ENSC"  [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1939002799800385537) 2025-06-28 16:47:47 UTC 29.8K followers, 6883 engagements
@BPharmCatalyst
"BioPharmCatalyst Weekly #Watchlist Key PDUFA and Regulatory Catalysts for the Next 6 Months $OMER $ABEO $RGNX $FBIO $CYTK $VNDA $OTLK $IONS $ARWR $TNXP $GRPH" @BPharmCatalyst on X 2025-07-14 13:17:37 UTC 29.8K followers, 6854 engagements
"$LGND today announced that its partner $PTHS has commercially launched ZELSUVMI (berdazimer) topical gel 10.3% the first and only FDA-approved at-home treatment for molluscum contagiosum. See More Biotech Updates👇 $CGTX $KLTO $RARE $MREO $CLDI $NTHI $PTHS" @BPharmCatalyst on X 2025-07-10 21:07:32 UTC 29.8K followers, 5223 engagements
"BioPharmCatalyst Weekly #Watchlist Key Phase 3 Catalysts for the Next 6 Months $ZYNE $PRAX $KPTI $AZN $DBVT $BTAI $AVBP $ABVX $XOMA $ENSC" @BPharmCatalyst on X 2025-06-30 13:53:24 UTC 29.8K followers, 6189 engagements
"$CLSD initiated a strategic review to explore options including asset sales partnerships or M&A to advance its SCS platform; Piper Sandler retained to lead the process. See More Biotech Updates👇 $WINT $SRPT $RCKT $FOLD $MBRX $CLSD $ICU" @BPharmCatalyst on X 2025-07-17 20:25:54 UTC 29.8K followers, 5188 engagements
"Want more info analysis and biotech news straight to your inbox Sign up for our FREE Daily and Weekly newsletters here:" @BPharmCatalyst on X 2025-07-16 21:44:57 UTC 29.8K followers, 1357 engagements
"🎧 New Episode Alert On Biotech Bulls and Breakthroughs John Gagliano and Sheff break down: 🔹 Key biotech market trends 🔹 Catalyst-driven trading strategies 🔹 Small-cap opportunities" @BPharmCatalyst on X 2025-07-14 11:38:00 UTC 29.8K followers, 76.5K engagements
"$NUWE announced the issuance by the U.S Patent and Trademark Office of U.S. Patent No. 12357734 titled "Extracorporeal Blood Filtering Machine and Methods." See More Biotech Updates👇 $SXTP $PMN $ANGO $BCTX $RANI $IKNA $KZR" @BPharmCatalyst on X 2025-07-15 20:49:05 UTC 29.8K followers, 2865 engagements
"BioPharmCatalyst Weekly #Watchlist Key PDUFA and Regulatory Catalysts for the Next 6 Months $OMER $ABEO $RGNX $FBIO $CYTK $VNDA $OTLK $IONS $ARWR $TNXP $GRPH" @BPharmCatalyst on X 2025-07-12 13:18:12 UTC 29.8K followers, 6509 engagements
"$INKT published new data in Oncogene highlighting a complete and durable remission in a patient with metastatic treatment-refractory testicular cancer treated with its iNKT cell therapy agenT-797. Additional case reports showed extended survival in several patients including 42% tumor reduction and 9+ months PFS in metastatic gastric cancer with agenT-797 + nivolumab. See More Pre-market Movers 👇 $CAPR $MIST $JUNS $PHVS" @BPharmCatalyst on X 2025-07-11 12:03:11 UTC 29.8K followers, 5311 engagements
"$SRPT announced a strategic restructuring to prioritize high-impact programs ensure financial sustainability through 2027 and focus on siRNA platform opportunities. The plan includes $400M in annual cost savings and a 36% workforce reduction (500 employees) aiming for long-term growth and profitability. See More Biotech Updates👇 $APM $CUE $CYCC $NUWE $QLGN $RPTX $GANX $CGTX $IKNA" @BPharmCatalyst on X 2025-07-16 20:29:56 UTC 29.8K followers, 6415 engagements
"$CGTX held an end-of-Phase 2 meeting with the FDA to review zervimesine (CT1812) data and discuss plans for a Phase 3 program to support a potential NDA in Alzheimer's disease. See More Pre-market Movers 👇 $KLTO $RARE $MREO $FONR $ALUR" @BPharmCatalyst on X 2025-07-10 12:04:56 UTC 29.8K followers, 5907 engagements
"BioPharmCatalyst Weekly #Watchlist Key Phase 1/2 catalyst for the next 6 months $CLLS $COGT $MRK $PMVP $GSK $MRSN $PEPG $ACIU $JSPR $CRSP $ENGN $JSPR $TIL" @BPharmCatalyst on X 2025-07-05 15:00:01 UTC 29.8K followers, 4057 engagements
"$MRK will acquire $VRNA for $107 per ADS in a deal valued at approximately $10 billion securing full ownership of Veronas respiratory drug assets. See More Pre-market Movers 👇 $KZIA $EVOK $PROK $ARTL $RXST $BCTX $BNTC $RYTM $ZVSA" @BPharmCatalyst on X 2025-07-09 12:33:08 UTC 29.8K followers, 5629 engagements
"$MBIO secured FDA Orphan Drug Designation for its IL-13R2-targeted CAR-T candidate MB-101 to treat malignant glioma unlocking eligibility for seven years of U.S. market exclusivity. See More Biotech Updates👇 $OGEN $CLRB $IGMS $VVOS $LIXT $ATAI $VRCA $MESO $MBIO" @BPharmCatalyst on X 2025-07-01 20:42:43 UTC 29.8K followers, 2834 engagements
"$EVOK received a USPTO Notice of Allowance for a patent covering GIMOTI use in moderate to severe gastroparesis expanding protection for its lead asset. See More Biotech Updates👇 $RXST $RYTM $BCTX $ZVSA $KZIA $VRNA $PROK" @BPharmCatalyst on X 2025-07-09 20:19:57 UTC 29.8K followers, 5149 engagements
"$WINT signed a $60M securities purchase agreement led by Build and Build Corp with the potential to raise a total of $200M to launch a BNB crypto treasury strategy. Subject to shareholder approval Windtree aims to become the first NASDAQ-listed company offering direct BNB token exposure. See More Pre-market Movers 👇 $WINT $SRPT $PRTC $RCKT $NUWE" @BPharmCatalyst on X 2025-07-17 12:23:48 UTC 29.8K followers, 4261 engagements
"$REVB announced that it will implement a 1-for-3 reverse stock split effective July 7 2025 following shareholder approval. See More Pre-market Movers 👇 $TIL $PTHS $CYBN $NLSP $GNTA" @BPharmCatalyst on X 2025-07-02 12:33:39 UTC 29.8K followers, 5311 engagements
"BioPharmCatalyst Weekly #Watchlist Key Catalysts Due in Mid-2025 $REPL $OTLK $RARE $WINT $ATAI $CYBN $IXHL $TNXP $VYNE $ATHE $PFE $CRDF $PRAX" @BPharmCatalyst on X 2025-07-19 15:00:00 UTC 29.8K followers, 1333 engagements
"$TELO reported promising data for Telomir-1 which showed it could reverse epigenetic gene silencing and restore tumor suppressors in human prostate cancer cells outperforming chemotherapy and rapamycin. See More Pre-market Movers 👇 $MESO $CNSP $SRPT $WINT $IINN" @BPharmCatalyst on X 2025-07-18 12:20:59 UTC 29.8K followers, 1982 engagements
"$MIST received a new PDUFA date of Dec 13 2025 for CARDAMYST nasal spray for PSVT after FDA accepted its CRL resubmission. The company also extended its $75M royalty deal with RTW through year-end. Separately Milestone priced a $52.5M public offering of common and pre-funded warrants at $1.50/share expected to close July 14 2025. See More Biotech Updates👇 $NCNA $INKT $MIST $CAPR $JUNS $PHVS $DARE" @BPharmCatalyst on X 2025-07-11 20:16:19 UTC 29.8K followers, 6067 engagements
"$SONN announced a business combination with Rorschach I LLC to form Hyperliquid Strategies Inc (HSI) a crypto treasury company expected to hold $888M in assets including 12.6M HYPE tokens and $305M in cash. HSI will remain listed on Nasdaq with backing from top crypto investors. See More Pre-market Movers 👇 $RANI $CELC $RARE $PRQR $IPA $EPIX $MGRM" @BPharmCatalyst on X 2025-07-14 12:23:23 UTC 29.8K followers, 5011 engagements
"BioPharmCatalyst Weekly #Watchlist Key Phase 3 Catalysts for the Next 6 Months $ZYNE $PRAX $KPTI $AZN $DBVT $BTAI $AVBP $ABVX $XOMA $ENSC" @BPharmCatalyst on X 2025-06-28 16:47:47 UTC 29.8K followers, 6883 engagements
/creator/twitter::56121651/posts